Teva- Pharmaceutical Industries Ltd
Teva- Pharmaceutical Industries Ltd (TEVA) Wheel Strategy
TEVA wheel strategy scan found 103 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 97.6%.
Read more
Running a TEVA wheel strategy lets you generate consistent premium income on Teva- Pharmaceutical Industries Ltd while setting your own entry and exit prices on the underlying. Teva- Pharmaceutical Industries Ltd's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own TEVA, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best TEVA wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on TEVA, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable TEVA wheel from a losing one.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas.
Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the TEVA wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your TEVA wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Oct 2, 2026 | 39.00 | $0.54 | $0.73 | -0.45 | 7 | 11% | 54.3% | 97.6% | 303 |
| Oct 9, 2026 | 39.00 | $0.70 | $0.89 | -0.45 | 14 | 11% | 52.9% | 59.2% | 158 |
| Oct 2, 2026 | 38.50 | $0.25 | $0.43 | -0.34 | 7 | 11% | 65.8% | 57.6% | 52 |
| Oct 9, 2026 | 38.50 | $0.47 | $0.77 | -0.38 | 14 | 11% | 61.1% | 52.1% | 0 |
| Oct 16, 2026 | 39.00 | $0.85 | $1.04 | -0.45 | 21 | 11% | 52.2% | 46.3% | 86 |
| Oct 30, 2026 | 39.00 | $1.17 | $1.49 | -0.45 | 35 | 11% | 51.6% | 39.7% | 71 |
| Nov 6, 2026 | 39.00 | $1.20 | $1.77 | -0.44 | 42 | 11% | 51.4% | 39.4% | 0 |
| Oct 23, 2026 | 39.00 | $0.69 | $1.12 | -0.45 | 28 | 11% | 51.9% | 37.4% | 30 |
| Oct 2, 2026 | 38.00 | $0.14 | $0.26 | -0.24 | 7 | 11% | 76.1% | 35.0% | 22 |
| Oct 9, 2026 | 38.00 | $0.27 | $0.51 | -0.30 | 14 | 11% | 68.9% | 35.0% | 194 |
As of September 25, 2026
Run the Wheel on TEVA With Confidence
Find the best TEVA wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→